Newsbenzinga
RBC Capital Maintains Outperform on Biogen, Raises Price Target to $242
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…